SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Sir John Franklin

PatientSir John Franklin
Date of birth1967-04-16
IdentifiersMRN HR-EX005-SYN; SSN (made up) 000-05-3328
Document date2026-02-24
AuthorCordelia Ashby-Nwankwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week review after starting amlodipine, two weeks after influenza. [S]

History of Present Illness

Sir John has taken amlodipine 5 mg every morning for four weeks. Two weeks ago he had influenza A, treated with five days of oseltamivir; the fever settled in three days, and he is left with a dry cough on cold mornings and tires earlier than usual on his walks, though he is walking two to three miles again. His home readings for the past week average 134/84. He has no ankle swelling, dizziness or flushing. He has lost 1.8 kg since intake. He had his echocardiogram this morning and brought a urine sample. His exercise treadmill test, booked for today, was postponed at the sick visit until he has been back to his usual activity for two weeks. [S]

ElementDetail
Home readingsSeven-day average 134/84 mmHg
InfluenzaRecovering; dry morning cough; tires earlier
AmlodipineNo side effects
EchocardiogramEjection fraction 62%; mild concentric remodeling
Urine albumin-to-creatinine ratio12 mg/g

Review of Systems

SystemResultFinding
ConstitutionalPositiveTires earlier than usual since influenza
RespiratoryPositiveDry cough on cold mornings; no breathlessness or sputum
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
NeurologicalNegativeNo dizziness

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet once dailyOne tablet by mouth every morningOral route2026-01-27activeS
Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar wintersOne tablet by mouth dailyOral route2026-01-27activeS
Oseltamivir 75 mg oral capsule twice daily for five daysOne capsule by mouth twice a day for five daysOral route2026-02-10 to 2026-02-14completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-24Body height170cmS
2026-02-24Body weight89kgS
2026-02-24Body mass index (BMI) [Ratio]30.8kg/m2S
2026-02-24Systolic blood pressure136mm[Hg]S
2026-02-24Diastolic blood pressure84mm[Hg]S
2026-02-24Heart rate80/minS
2026-02-24Respiratory rate16/minS
2026-02-24Body temperature36.7CelS
2026-02-24Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-24Albumin/Creatinine [Mass Ratio] in Urine12mg/gBelow 30 mg/g normalNormalS
2026-02-24Left ventricular Ejection fraction62%52-72%NormalS

Physical Exam

Vital signs recorded on 2026-02-24; see the Vital Signs section. [S]

SystemFinding
GeneralWell; afebrile; blood pressure 136/84, pulse 80; weight 89.0 kg, BMI 30.8
RespiratoryClear to auscultation
CardiovascularRegular rhythm; no murmur; no edema

Problems

ProblemClinical statusVerificationCodeProvenance
High blood pressure found at the pre-expedition medical (152/94 mmHg, average of two readings), without a prior diagnosis; home readings for one week ordered to confirmresolvedconfirmed R03.0S — Synthetic presenting finding at a pre-expedition fitness assessment, anchored to the documented doubts about his fitness; superseded when home readings confirmed hypertension.
Essential hypertension, stage 2 by home readings (one-week average 144/90 mmHg), without target-organ damage; syntheticactiveconfirmed I10S — Synthetic modern diagnosis confirmed by home monitoring at the consultation; no blood pressure from his lifetime is recorded.
Obesity, class 1 (BMI 31.4 at intake), with a waist of 106 cm; he sets his own goals for activity and foodactiveconfirmed E66.811S — Synthetic modern finding anchored to the documented description of his build as portly; no weight from his lifetime is recorded.
Medical preparation for a multi-year Arctic expedition beyond the reach of hospital care: fitness, cold injury, nutrition and food safety, vaccinations, dental care, mental health in isolation, a medical kit and an evacuation planactiveconfirmed Z71.84S — Synthetic travel-health problem anchored to the documented expedition.
Bilateral high-frequency sensorineural hearing loss from noise, mild; trouble hearing in noisy roomsactiveconfirmed H83.3X3S — Synthetic modern coding of the documented mild hearing loss from naval gunfire; the audiogram is synthetic.
Vitamin D insufficiency in midwinter (25-hydroxyvitamin D 22 ng/mL), with years of polar darkness aheadactiveconfirmed E55.9S — Synthetic laboratory finding at intake.
Influenza A, confirmed by rapid molecular test, with fever, cough and aches, without pneumonia; treated with oseltamivir; recovered with a lingering coughresolvedconfirmed J10.1S — Synthetic modern illness anchored to the documented severe influenza of the winter before the expedition; the test, course and treatment are synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationOffice blood pressure (seated, five minutes' rest, large cuff, average of two readings)Every visitCompleted today136/84 mmHg
Self-managementHome blood pressure monitoringAt diagnosis and two to four weeks after each treatment change, then weeklyCompleted todayAverage 134/84 mmHg four weeks after starting amlodipine
ExaminationWeight, BMI and waistEvery visitCompleted today89.0 kg, BMI 30.8
ExaminationCardiac auscultationEvery visitCompleted todayNo murmur or gallop
LaboratoryUrine albumin-to-creatinine ratioAt diagnosis, then yearlyCompleted today12 mg/g, normal; the sample deferred from intake
LaboratoryBasic metabolic panel, potassium and eGFRYearly (every six months only on a diuretic or renin-angiotensin blocker)Up to dateNot needed for amlodipine; yearly
ImagingEchocardiogramAt diagnosis of stage 2 hypertension or suspected left ventricular hypertrophyCompleted todayEjection fraction 62%; mild concentric remodeling, septum 11 mm; normal valves
Medication safetyAmlodipine safety: ankle swelling, dizziness, flushingAt each visitCompleted todayNo ankle swelling, dizziness or flushing
ExaminationExercise treadmill test before strenuous remote workBefore clearanceDuePostponed at the sick visit until two weeks of usual activity after influenza; rebooked for the eight-week review
ReferralWilderness and expedition medicine consultationBefore clearance for remote dutyUp to dateSeen four weeks ago

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and hyperlipidemia monographs (2026); Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions (2018); Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza (2018)

Follow-up: Preventive visit with vaccinations in two weeks. Eight-week review with the exercise treadmill test. Call for breathlessness or a worsening cough. Next scheduled visit 2026-03-10: periodic adult preventive visit. [S]